By David Tuller, DrPH When the PACE trial was published in early 2011, my New York Times editor sent it to me, along with the press release. As a non-staff contributor to the Times, I had started covering the debate over the mouse retrovirus hypothesis and science, but I'd heard ...

By David Tuller, DrPH Earlier this month, in advance of a stakeholder meeting, the U.K.'s National Institute for Health and Care Excellence released a draft scoping report. The document outlined the issues slated to be addressed by the committee selected to develop the new guidance for the illness NICE now ...

By David Tuller, DrPH It’s been almost a year since the CDC removed its recommendations for GET and CBT as treatments for ME/CFS (or CFS, or ME, or CFS/ME, or even SEID or whatever else one calls this illness or cluster of illnesses). When questioned about the decision, the agency ...

By David Tuller, DrPH Last year, BMJ Open published a paper called Randomised controlled trial of online continuing education for health professionals to improve the management of chronic fatigue syndrome: a study protocol. The seven authors, all affiliated with the University of New South Wales in Sydney, included Professor Andrew ...

By David Tuller, DrPH Saturday, May 12th, is International ME Awareness Day. (It's also International Fibromyalgia Awareness Day, and the same for Gulf War Illness and Multiple Chemical Sensitivity. But here we're mostly focused on the first.) This day in the calendar was adopted years ago as an opportunity to ...